LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: A review of new atypical antipsychotic launches in the United States.

    Ventimiglia, Jeff / Kalali, Amir H / Citrome, Leslie

    Psychiatry (Edgmont (Pa. : Township))

    2010  Volume 7, Issue 12, Page(s) 13–15

    Abstract: In this article we investigate the post-launch retail prescription trends of asenapine (Saphris(®), Merck and Co.) and iloperidone (Fanapt(®), Vanda Pharmaceuticals Inc./Novartis), two new atypical antipsychotics to launch in the United States market in ... ...

    Abstract In this article we investigate the post-launch retail prescription trends of asenapine (Saphris(®), Merck and Co.) and iloperidone (Fanapt(®), Vanda Pharmaceuticals Inc./Novartis), two new atypical antipsychotics to launch in the United States market in October 2009 and January 2010, respectively. In the first 12 months following the asenapine launch, and in the nine months since the iloperidone launch, asenapine and iloperidone have secured 0.22 and 0.10 percent of the total prescription market; however, both products nearly double those respective shares when total prescriptions are isolated to new patient prescriptions (0.44% for asenapine and 0.17% for iloperidone). Since launch, asenapine has shown stronger signs of growth, largely attributed to its approval in multiple indications as compared to iloperidone's single indication.
    Language English
    Publishing date 2010-05-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2528825-8
    ISSN 1555-5194 ; 1555-5194
    ISSN (online) 1555-5194
    ISSN 1555-5194
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: An analysis of the intended use of atypical antipsychotics in dementia.

    Ventimiglia, Jeff / Kalali, Amir H / Vahia, Ipsit V / Jeste, Dilip V

    Psychiatry (Edgmont (Pa. : Township))

    2010  Volume 7, Issue 11, Page(s) 14–17

    Abstract: In this article, the authors explore trends in intended usage of atypical antipsychotics to treat dementia following the United States Food and Drug Administration advisory safety warning issued in April 2005. Analysis suggests that physician-reported ... ...

    Abstract In this article, the authors explore trends in intended usage of atypical antipsychotics to treat dementia following the United States Food and Drug Administration advisory safety warning issued in April 2005. Analysis suggests that physician-reported intended usage of antipsychotics to treat dementia has declined by nearly 50 percent over the past five years. When reviewing the products intended for use in the treatment of patients with dementia, atypical intended usage has declined considerably while the intended usage of anti-Alzheimer's disease treatments has grown to replace those shares.
    Language English
    Publishing date 2010-09-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2528825-8
    ISSN 1555-5194 ; 1555-5194
    ISSN (online) 1555-5194
    ISSN 1555-5194
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top